The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Imaging Prostate Cancer: A Multidisciplinary Perspective
Abstract
The major goal for prostate cancer imaging in the next decade is more accurate disease characterization through the synthesis of anatomic, functional, and molecular imaging information. No consensus exists regarding the use of imaging for evaluating primary prostate cancers. Ultrasonography is mainly used for biopsy guidance and brachytherapy seed placement. Endorectal magnetic resonance (MR) imaging is helpful for evaluating local tumor extent, and MR spectroscopic imaging can improve this evaluation while providing information about tumor aggressiveness. MR imaging with superparamagnetic nanoparticles has high sensitivity and specificity in depicting lymph node metastases, but guidelines have not yet been developed for its use, which remains restricted to the research setting. Computed tomography (CT) is reserved for the evaluation of advanced disease. The use of combined positron emission tomography/CT is limited in the assessment of primary disease but is gaining acceptance in prostate cancer treatment follow-up. Evidence-based guidelines for the use of imaging in assessing the risk of distant spread of prostate cancer are available. Radionuclide bone scanning and CT supplement clinical and biochemical evaluation (prostate-specific antigen [PSA], prostatic acid phosphate) for suspected metastasis to bones and lymph nodes. Guidelines for the use of bone scanning (in patients with PSA level > 10 ng/mL) and CT (in patients with PSA level > 20 ng/mL) have been published and are in clinical use. Nevertheless, changes in practice patterns have been slow. This review presents a multidisciplinary perspective on the optimal role of modern imaging in prostate cancer detection, staging, treatment planning, and follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
Pound, C. R. (1999) · JAMA · doi:10.1001/jama.281.17.1591 · Cited by 3,071
Gleason, D. F., Mellinger, G. T., & The Veterans Administration Cooperative Urological Research Group Members of this group areS0022534717598894-57c401330b4195dbd1713587ed540477 Lino J. Arduino Veterans Administration Center (VAC), D. M. (1974) · Journal of Urology · doi:10.1016/s0022-5347(17)59889-4 · Cited by 2,214
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial
Pollack, A., Zagars, G. K., Starkschall, G., Antolak, J. A., Lee, J. J., Huang, E., von Eschenbach, A. C., Kuban, D. A., & Rosen, I. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02829-8 · Cited by 1,333
Positron emission tomography provides molecular imaging of biological processes
Phelps, M. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9226 · Cited by 1,229
Zietman, A. L., DeSilvio, M. L., Slater, J. D., Rossi, C. J., Miller, D. W., Adams, J. A., & Shipley, W. U. (2005) · JAMA · doi:10.1001/jama.294.10.1233 · Cited by 1,224
Messing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D., & Trump, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412401 · Cited by 1,191
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
Partin, A. W., Mangold, L. A., Lamm, D. M., Walsh, P. C., Epstein, J. I., & Pearson, J. D. (2001) · Urology · doi:10.1016/s0090-4295(01)01441-8 · Cited by 1,038
CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTS
HULL, G. W., RABBANI, F., ABBAS, F., WHEELER, T. M., KATTAN, M. W., & SCARDINO, P. T. (2002) · Journal of Urology · doi:10.1016/s0022-5347(01)69079-7 · Cited by 964
Self-citationTowards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality
Ling, C. C., Humm, J., Larson, S., Amols, H., Fuks, Z., Leibel, S., & Koutcher, J. A. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00467-3 · Cited by 926
Self-citationVariations in Morbidity after Radical Prostatectomy
Begg, C. B., Riedel, E. R., Bach, P. B., Kattan, M. W., Schrag, D., Warren, J. L., & Scardino, P. T. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa011788 · Cited by 840
Self-citationSilverberg, E., Boring, C. C., & Squires, T. S. (1990) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.40.1.9 · Cited by 816
Intensity-modulated radiotherapy: current status and issues of interest
(2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01749-7 · Cited by 767
Benson, M. C., Whang, I. S., Pantuck, A. J., Ring, K. S., Kaplan, S. A., Olsson, C. A., & Cooner, W. H. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)37393-7 · Cited by 763
Postoperative Nomogram for Disease Recurrence After Radical Prostatectomy for Prostate Cancer
Kattan, M. W., Wheeler, T. M., & Scardino, P. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1499 · Cited by 741
Self-citationZELEFSKY, M. J., FUKS, Z., HUNT, M., LEE, H. J., LOMBARDI, D., LING, C. C., REUTER, V. E., VENKATRAMAN, E. S., & LEIBEL, S. A. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)65855-7 · Cited by 697
Self-citationZincke, H., Oesterling, J. E., Blute, M. L., Bergstralh, E. J., Myers, R. P., & Barrett, D. M. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32399-6 · Cited by 672
Weber, G. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703032960905 · Cited by 641
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
Jager, P. L., Vaalburg, W., Pruim, J., de Vries, E. G. E., Langen, K., & Piers, D. (2001) · PubMed · Cited by 558
Bianco, F. J., Scardino, P. T., & Eastham, J. A. (2005) · Urology · doi:10.1016/j.urology.2005.06.116 · Cited by 553
Self-citation5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer
Catalona, W. J., & Smith, D. S. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32397-2 · Cited by 502
Comparison of Magnetic Resonance Imaging and Ultrasonography in Staging Early Prostate Cancer
Rifkin, M. D., Zerhouni, E. A., Gatsonis, C. A., Quint, L. E., Paushter, D. M., Epstein, J. I., Hamper, U. M., Walsh, P. C., & McNeil, B. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009063231001 · Cited by 500
Determination of Prostate Volume by Transrectal Ultrasound
Terris, M. K., & Stamey, T. A. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)38508-7 · Cited by 491
Image guidance for precise conformal radiotherapy
Mackie, T. R., Kapatoes, J., Ruchala, K., Lu, W., Wu, C., Olivera, G., Forrest, L., Tome, W., Welsh, J., Jeraj, R., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00090-7 · Cited by 484
Over-expression of facilitative glucose transporter genes in human cancer
Yamamoto, T., Seino, Y., Fukumoto, H., Koh, G., Yano, H., Inagaki, N., Yamada, Y., Inoue, K., Manabe, T., & Imura, H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91263-r · Cited by 465
Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to α v β 3
Ellegala, D. B., Leong-Poi, H., Carpenter, J. E., Klibanov, A. L., Kaul, S., Shaffrey, M. E., Sklenar, J., & Lindner, J. R. (2003) · Circulation · doi:10.1161/01.cir.0000080326.15367.0c · Cited by 454
Enzymology of Cancer Cells: (Second of Two Parts)
Weber, G. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703102961005 · Cited by 416
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
SHREVE, P. D., Grossman, H. B., Gross, M. D., & Wahl, R. L. (1996) · Radiology · doi:10.1148/radiology.199.3.8638000 · Cited by 395
The Clinical Usefulness of Prostate Specific Antigen: Update 1994
Partin, A. W., & Oesterling, J. E. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32422-9 · Cited by 390
Engelbrecht, M. R., Huisman, H. J., Laheij, R. J. F., Jager, G. J., van Leenders, G. J. L. H., Hulsbergen-Van De Kaa, C. A., de la Rosette, J. J. M. C. H., Blickman, J. G., & Barentsz, J. O. (2003) · Radiology · doi:10.1148/radiol.2291020200 · Cited by 380
Akin, O., Sala, E., Moskowitz, C. S., Kuroiwa, K., Ishill, N. M., Pucar, D., Scardino, P. T., & Hricak, H. (2006) · Radiology · doi:10.1148/radiol.2392050949 · Cited by 379
Self-citationAMLING, C. L., BLUTE, M. L., BERGSTRALH, E. J., SEAY, T. M., SLEZAK, J., & ZINCKE, H. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67457-5 · Cited by 368
Risk of prostate carcinoma death in patients with lymph node metastasis
Cheng, L., Zincke, H., Blute, M. L., Bergstralh, E. J., Scherer, B., & Bostwick, D. G. (2001) · Cancer · doi:10.1002/1097-0142(20010101)91:1<66::aid-cncr9>3.0.co;2-p · Cited by 363
Serial Biopsy Results in Prostate Cancer Screening Study
ROEHL, K. A., ANTENOR, J. A. V., & CATALONA, W. J. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64999-3 · Cited by 362
Vesselle, H. J., Schmidt, R. A., Pugsley, J. M., Li, M., Kohlmyer, S. G., Vallires, E., & Wood, D. E. (2000) · PubMed · Cited by 351
EASTHAM, J. A., KATTAN, M. W., RIEDEL, E., BEGG, C. B., WHEELER, T. M., GERIGK, C., GONEN, M., REUTER, V., & SCARDINO, P. T. (2003) · Journal of Urology · doi:10.1097/01.ju.0000091100.83725.51 · Cited by 338
Self-citationRole of Surgeon Volume in Radical Prostatectomy Outcomes
Hu, J. C., Gold, K. F., Pashos, C. L., Mehta, S. S., & Litwin, M. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.169 · Cited by 333
Sato, C., Naganawa, S., Nakamura, T., Kumada, H., Miura, S., Takizawa, O., & Ishigaki, T. (2005) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20251 · Cited by 323
Kattan, M. W., Zelefsky, M. J., Kupelian, P. A., Scardino, P. T., Fuks, Z., & Leibel, S. A. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3352 · Cited by 320
Self-citationBartsch, G., Horninger, W., Klocker, H., Reissigl, A., Oberaigner, W., Schönitzer, D., Severi, G., Robertson, C., & Boyle, P. (2001) · Urology · doi:10.1016/s0090-4295(01)01264-x · Cited by 315
Effert, P. J., Bares, R., Handt, S., Wolff, J. M., Büll, U., & Jakse, G. (1996) · PubMed · Cited by 289
Liu, I. J., Zafar, M. B., Lai, Y.-H., Segall, G. M., & Terris, M. K. (2001) · Urology · doi:10.1016/s0090-4295(00)00896-7 · Cited by 267
Bellin, M. F., Roy, C., Kinkel, K., Thoumas, D., Zaim, S., Vanel, D., Tuchmann, C., Richard, F., Jacqmin, D., Delcourt, A., et al. (1998) · Radiology · doi:10.1148/radiology.207.3.9609907 · Cited by 261
Hofer, C., Laubenbacher, C., Block, T., Breul, J., Härtung, R., & Schwaiger, M. (1999) · European Urology · doi:10.1159/000019923 · Cited by 252
Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.
Brown, R. S., Leung, J. Y., Kison, P. V., Zasadny, K. R., Flint, A., & Wahl, R. L. (1999) · PubMed · Cited by 247
Coakley, F. V., Eberhardt, S., Kattan, M. W., Wei, D. C., Scardino, P. T., & Hricak, H. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64568-5 · Cited by 242
Self-citationEffert, P. J., Bares, R., Handt, S., Wolff, J. M., Bull, U., & Jakse, G. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66366-3 · Cited by 240
Lee, F., McLeary, R. D., Kumasaka, G. H., Borlaza, G. S., Straub, W. H., Gray, J. M., Meadows, T. R., Lee, F., Solomon, M. H., McHugh, T. A., et al. (1985) · The Prostate · doi:10.1002/pros.2990070202 · Cited by 237
GORE, J. L., SHARIAT, S. F., MILES, B. J., KADMON, D., JIANG, N., WHEELER, T. M., & SLAWIN, K. M. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)66347-1 · Cited by 233
Kattan, M. W., Stapleton, A. M. �., Wheeler, T. M., & Scardino, P. T. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<528::aid-cncr15>3.0.co;2-5 · Cited by 230
Self-citationOncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
Delbeke, D. (1999) · PubMed · Cited by 227
Swanson, M. G., Vigneron, D. B., Tabatabai, Z. L., Males, R. G., Schmitt, L., Carroll, P. R., James, J. K., Hurd, R. E., & Kurhanewicz, J. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10614 · Cited by 223
Combining anatomy and function: the path to true image fusion
Townsend, D. W., & Cherry, S. R. (2001) · European Radiology · doi:10.1007/s003300101007 · Cited by 221
Buckley, D. L., Roberts, C., Parker, G. J. M., Logue, J. P., & Hutchinson, C. E. (2004) · Radiology · doi:10.1148/radiol.2333032098 · Cited by 215
Pucar, D., Shukla-Dave, A., Hricak, H., Moskowitz, C. S., Kuroiwa, K., Olgac, S., Ebora, L. E., Scardino, P. T., Koutcher, J. A., & Zakian, K. L. (2005) · Radiology · doi:10.1148/radiol.2362040739 · Cited by 198
Self-citationOyen, R. H., Van Poppel, H. P., Ameye, F. E., Van de Voorde, W. A., Baert, A. L., & Baert, L. V. (1994) · Radiology · doi:10.1148/radiology.190.2.8284375 · Cited by 198
Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.
Reske, S. N., Grillenberger, K. G., Glatting, G., Port, M., Hildebrandt, M., Gansauge, F., & Beger, H. G. (1997) · PubMed · Cited by 197
Morris, M. J., Akhurst, T., Osman, I., Nunez, R., Macapinlac, H., Siedlecki, K., Verbel, D., Schwartz, L., Larson, S. M., & Scher, H. I. (2002) · Urology · doi:10.1016/s0090-4295(02)01509-1 · Cited by 195
MULLERAD, M., HRICAK, H., KUROIWA, K., PUCAR, D., CHEN, H.-N., KATTAN, M. W., & SCARDINO, P. T. (2005) · Journal of Urology · doi:10.1097/01.ju.0000181224.95276.82 · Cited by 193
Self-citationHricak, H., Wang, L., Wei, D. C., Coakley, F. V., Akin, O., Reuter, V. E., Gonen, M., Kattan, M. W., Onyebuchi, C. N., & Scardino, P. T. (2004) · Cancer · doi:10.1002/cncr.20319 · Cited by 184
Self-citationWolf, J. S., Cher, M. L., Dall’Era, M., Presti, J. C., Hricak, H., & Carroll, P. R. (1995) · PubMed · Cited by 181
Self-citationFDG PET measurement of the proliferative potential of non-small cell lung cancer.
Higashi, K., Ueda, Y., Yagishita, M., Arisaka, Y., Sakurai, A., Oguchi, M., Seki, H., Nambu, Y., Tonami, H., & Yamamoto, I. (2000) · PubMed · Cited by 172
Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and1H MR Spectroscopy
Claus, F. G., Hricak, H., & Hattery, R. R. (2004) · RadioGraphics · doi:10.1148/24si045516 · Cited by 158
Self-citationOncological applications of FDG PET imaging.
Delbeke, D. (1999) · PubMed · Cited by 151
Sala, E., Akın, O., Moskowitz, C. S., Eisenberg, H. F., Kuroiwa, K., Ishill, N. M., Rajashanker, B., Scardino, P. T., & Hricak, H. (2006) · Radiology · doi:10.1148/radiol.2383050657 · Cited by 150
Self-citationPollack, A. S., Zagars, G. K., Antolak, J. A., Kuban, D. A., & Rosen, I. I. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02977-2 · Cited by 147
Presti, J. C., Hricak, H., Narayan, P. A., Shinohara, K., White, S., & Carroll, P. R. (1996) · American Journal of Roentgenology · doi:10.2214/ajr.166.1.8571856 · Cited by 142
Self-citationChemotherapy for prostate cancer
Gilligan, T. D., & Kantoff, P. W. (2002) · Urology · doi:10.1016/s0090-4295(02)01583-2 · Cited by 127
Comparison of biochemical failure definitions for permanent prostate brachytherapy
Kuban, D. A., Levy, L. B., Potters, L., BEYER, D. C., Blasko, J. C., Moran, B. J., Ciezki, J. P., Zietman, A. L., Zeléfsky, M. J., Pisansky, T. M., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.03.027 · Cited by 118
Sanz, Sanz, Robles, J. E., Giménez, Arocena, Sánchez, Sánchez, Rodriguez‐Rubio, Rosell, Richter, et al. (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00349.x · Cited by 109
Wang, L., Hricak, H., Kattan, M. W., Schwartz, L. H., Eberhardt, S. C., Chen, H.-N., & Scardino, P. T. (2006) · American Journal of Roentgenology · doi:10.2214/ajr.04.1682 · Cited by 90
Self-citationPROSTATE SPECIFIC ANTIGEN NADIR ACHIEVED BY MEN APPARENTLY CURED OF PROSTATE CANCER BY RADIOTHERAPY
Critz, F. A., Levinson, A., Williams, W. H., HOLLADAY, C. T., GRIFFIN, V. D., & Holladay, D. A. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61631-8 · Cited by 55
Macapinlac, H. A. (1999) · Clinical Positron Imaging · doi:10.1016/s1095-0397(99)00015-1 · Cited by 50
Touijer, K. A., Kuroiwa, K., Vickers, A. J., Reuter, V. E., Hricak, H., Scardino, P. T., & Guillonneau, B. D. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.065 · Cited by 47
Self-citationManagement of patients with rising prostate-specific antigen after radical prostatectomy
Laufer, M., Pound, C. R., Carducci, M. A., & Eisenberger, M. A. (2000) · Urology · doi:10.1016/s0090-4295(99)00465-3 · Cited by 43
Ohori, M., & Scardino, P. T. (2002) · Current Problems in Surgery · doi:10.1067/msg.2002.126335 · Cited by 40
Self-citationElevation of Facilitated Glucose–Transporter Messenger Rna in Human Hepatocellular Carcinoma
Su, T., Tsai, T., Chi, C., Han, S., & Chou, C. (1990) · Hepatology · doi:10.1002/hep.1840110120 · Cited by 39
Rørvik, O. J. H. J. (1998) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655998750014486 · Cited by 33
Cited by
Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
Eiber, M., Weirich, G., Holzapfel, K., Souvatzoglou, M., Haller, B., Rauscher, I., Beer, A. J., Wester, H.-J., Gschwend, J., Schwaiger, M., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.12.053 · Cited by 568
Prostate Specific Antigen Best Practice Statement: 2009 Update
Greene, K. L., Albertsen, P. C., Babaian, R. J., Carter, H. B., Gann, P. H., Han, M., Kuban, D. A., Sartor, A. O., Stanford, J. L., Zietman, A., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.093 · Cited by 517
Szabo, Z., Mena, E., Rowe, S. P., Plyku, D., Nidal, R., Eisenberger, M. A., Antonarakis, E. S., Fan, H., Dannals, R. F., Chen, Y., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0850-8 · Cited by 443
Vargas, H. A., Akin, O., Franiel, T., Mazaheri, Y., Zheng, J., Moskowitz, C., Udo, K., Eastham, J., & Hricak, H. (2011) · Radiology · doi:10.1148/radiol.11102066 · Cited by 402
Self-citationMRI-Guided Focused Ultrasound Surgery
Jolesz, F. A. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041707.170303 · Cited by 377
Metadata
- Authors
- Hricak, H., Choyke, P. L., Eberhardt, S. C., Leibel, S. A., & Scardino, P. T.
- Venue
- Radiology
- Published
- 2007-04
- Volume
- 243
- Issue
- 1
- Pages
- 28-53
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2164051596
- Cited by
- 601
- References
- 79
- FWCI
- 41.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.